Prenatal Test Maker Faces Investor Suit Over False Positives
Biotechnology and women's health company Natera got hit with a proposed shareholder class action after a series of stock drops followed revelations that Natera's prenatal test for genetic disorders allegedly gives...To view the full article, register now.
Already a subscriber? Click here to view full article